Benefits were observed in AF patients irrespective of age, gender, stroke risk, type of AF, prior stroke, and co-morbidities such as hypertension and diabetes, notes Stuart Connolly, director of McMaster University???s division of cardiology and co-principal investigator for the RE-LY study.